Management of osteoporosis after gynecological cancer

Breast Cancer remains the most frequent cancer in women. Women with breast cancer now expect to live longer than before and the prevention of morbidity induced by cancer treatment is a concern. In ER-positive Breast Cancer, the goal of Adjuvant treatment is to inhibit the impact of estrogen on the breast. Aromatase inhibitors are associated with increased bone loss. Critical is the role of a careful baseline evaluation of the risk of fracture in all postmenopausal women with breast cancer and especially in the cases treated with aromatase inhibitors.
Source: Maturitas - Category: Primary Care Authors: Tags: Abstract ID: 115 Source Type: research